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ABSTRACT
Objective: To assess the anticonvulsant activity of ethanolic extract of Citrus maximus (EECM) leaves of maximal electroshock seizure (MES) and 
pentylenetetrazol (PTZ)-induced seizure models on albino (Wistar strain) rats and mice.
Methods: Anticonvulsant activity was carried out by MES model and PTZ-induced clonic convulsions model; in each model, albino rats (Wistar strain) 
of either sex were taken and divided into five groups, each consisting of 6 rats. One group was used as control (3% w/v gum acacia), one as standard 
(phenytoin), and three groups for the test drug of EECM leaves (doses of 50, 100, and 200 mg/kg) treatment. The reduction in time or abolition of tonic 
extensor phase of MES-convulsions was recorded for all the animals. In PTZ model, either delay or complete abolition of convulsions in rats treated 
with diazepam and EECM leaves was noted for all the animals.
Result: EECM leaves reduced the extensor phase of convulsion in MES in a dose-dependent manner and decrease in the duration of convulsions in PTZ 
model with increasing dose. Anticonvulsant activity was seen maximum at the dose of 200 mg/kg.
Conclusions: Thus, from the above two seizure models of MES and PTZ, it can be concluded that EECM leaves have got an anticonvulsant effect in an 
increasing dose-dependent manner.
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INTRODUCTION
Epilepsy describes a condition, in which a person has recurrent seizures 
due to a chronic, underlying process. This implies that a person with 
a single seizure, or recurrent seizures due to correctable or avoidable 
circumstances, does not necessarily have epilepsy. Epilepsy refers to a 
clinical phenomenon rather than a single disease entity. Since there are 
many forms and causes of epilepsy. However, among the many causes 
of epilepsy, there are various epilepsy syndromes, in which the clinical 
and pathological characteristics are distinctive and suggest a specific 
underlying etiology [1].
Citrus maximus is commonly known as pomelo (English), rabab-tenga 
(Assamese), Chinese grapefruit, pummelo, pummel jabot, shaddock, or 
Jeruk Bali. It is a citrus fruit which belongs to the Rutaceae family and 
is usually pale green to yellow when ripe, with sweet flesh and thick 
spongy ring [2].
C. maximus has been used in the traditional medicine in Asia for 100 
of years. The decoctions of the leaves, flowers, and rind are used for 
their sedative effect in cases of epilepsy, chorea, and severe cough. The 
hot leaf decoction is applied on swellings and ulcers. The fruit juice 
is taken as a febrifuge. The sarcocarps are employed against coughs, 
dyspepsia, and lumbago. The pulp is considered an effective aid in the 
treatment of urinary disorders. Leaf extractions have shown antibiotic 
activity [3]. Traditional medicinal plants with various active principles 
and properties have been used since ancient times by physicians and 
laymen to treat a variety of diseases such as epilepsy. The anticonvulsant 
activity of Citrus maximus leaves has not been studied earlier in the 
north-eastern region of India. Keeping in view with the above ideas, 
the present study has been undertaken to evaluate the anticonvulsant 
activity of C. maximus leaves in albino rats and mice, respectively.
METHODS
Collection of plant material
C. maximus leaves were collected from the PG-Hostel campus of Assam 
Medical College, Dibrugarh, in the month of March and identified 
by Botanist, Department of Life Sciences, Dibrugarh University, 
Dibrugarh, Assam, India, with identification voucher number being 
DU/LS/208.
Method of extraction
The required amount of leaves of C. maximus was collected and dried 
at room temperature. The dried leaves were ground into powder 
separately. Sufficient amount of powdered leaves was moistened with 
95% ethyl alcohols and allowed to remain for 6 hrs in a percolator. 
When the liquid began to drop from the percolator, the orifice was 
closed and the content was allowed to macerate for 24 hrs. After 24 hrs, 
it was allowed to percolate slowly, a rate not exceeding 1 ml/minutes [4] 
and the solution was collected in Petri dishes. Alcohol was allowed to 
evaporate at room temperature. When the extract got completely dried, 
it was scrapped out, weighed and stored [4] and the yield at the end of 
extraction was found to be 16.7 g.
Acute toxicity testing
In the present study, for acute toxicity testing for both oral (not 
intended route) and intraperitoneal (i.p.) (intended route), routes were 
performed. Oral acute toxicity testing was studied in albino mice as well 
as in albino rats according to the OECD Guidelines for 425 [5], and no 
mortality was recorded up to the dose of 2000 mg/kg.
Grouping and preparation of drug doses
a. Vehicle (Group A): 3% (w/v) gum acacia suspension was prepared 
and used in the control group.
b. Test drugs (Group B1, Group B2, and Group B3): 50, 100, and 
200 mg/kg of the ethanolic extract of C. maximus (EECM) leaves 
were prepared with 3% (w/v) gum acacia as a suspending agent.
c. Standard drugs (Group C): For anticonvulsant models-phenytoin 
25 mg/kg, and diazepam 4 mg/kg. All the suspensions of phenytoin 
and diazepam were prepared with 3% (w/v) gum acacia.
d. CNS stimulant: Pentylenetetrazol (PTZ) 40 mg/kg [6], a stock 
solution containing 4 mg/ml of the drug was prepared using distilled 
water.
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EXPERIMENTAL PROCEDURES
Permission of the Institutional Animal Ethical Committee was obtained 
before conducting the study.
Maximal electroshock seizure (MES) model
Induction of the MES, using an electroconvulsiometer, is a commonly 
used model for evaluation of anticonvulsant drugs.
Healthy albino rats (Wistar strain) of either sex were taken and 
divided into five groups, each consisting of 6 rats. One group was 
used as control (3% w/v gum acacia), one as standard (phenytoin), 
and three groups for the test drug (EECM in the doses of 50, 100, and 
200 mg/kg) treatment.
• Each animal was properly held, and earlobe electrodes were placed 
on the earlobes and current of 150 mA was passed for 0.2 seconds. 
Different stages of convulsions as mentioned earlier were noted 
down, along with the time (seconds) spent by the animal in each 
phase of the convulsions. The same procedure was repeated 
with other animals of the control group. The current was passed 
30 minutes after i.p. injection of 3% (w/v) gum acacia.
• For the test drug groups, the same procedure as the earlier step was 
repeated for three different doses (50, 100, and 200 mg/kg, i.p.) of 
EECM.
• Phenytoin (standard) was also injected i.p. to all the 6 rats. After 
waiting for 30 minutes, animals were subjected to electroconvulsions 
as described in the earlier steps.
• The reduction in time or abolition of tonic extensor phase of MES-
convulsions was recorded for all the animals [7].
PTZ-induced clonic convulsions
Healthy albino rats (Wistar strain) of either sex were taken and divided 
into five groups, each consisting of 6 rats. One group as a control, one as 
standard (diazepam), and three as tests (EECM in the doses of 50, 100, 
and 200 mg/kg) were taken for the study.
• 3% (w/v) gum acacia was injected intraperitoneally to the control 
animals, and after 30 minutes, PTZ was injected subcutaneously to 
these animals, and the onset of action (indicated by Straub’s tail, 
jerky movements of the whole body and convulsions) and severity 
of convulsions due to the drug were noted.
• EECM in the doses of 50, 100, and 200 mg/kg were taken as test drug 
groups, and the same procedure as the earlier step was followed.
• Diazepam was injected intraperitoneally to a group of 6 rats, which 
were taken as the standard group. After waiting for 30 minutes, the 
animals were subjected to subcutaneous injection of PTZ as described 
in the earlier step.
• Either delay or complete abolition of convulsions in rats treated with 
diazepam and EECM was noted [7].
RESULTS
Statistical analysis
The data were statistically analyzed using one-way analysis of variance 
(ANOVA) test, followed by Dunnett’s multiple-comparison test, using 
the GraphPad Prism 5 software (Tables 1 and 2).
DISCUSSION
The present study was undertaken to evaluate an anticonvulsant 
activity of the EECM leaves in experimental animal models.
Although the MES test predicts activity against generalized tonic-clonic 
and cortical focal seizures and the PTZ test against absence seizures, the 
underlying neuronal abnormality is not well understood. Diminution of 
brain GABA level has been reported after subconvulsive dose of PTZ [8].
The MES-induced convulsions for the screening of the anticonvulsant 
drug are the standard experimental model for evaluating a drug in 
experimental animals its anticonvulsant property, which represents 
grand mal epilepsy in human beings [7].
The anticonvulsant effect by the MES model is determined by the effect 
of the drug in the tonic hindlimb extensor phase of the convulsion [9]. 
By either completely abolishing it or by reducing its duration [7]. In the 
present study, it was found that the duration of the extensor phase in the 
control group was 12.5±0.428 seconds, which is similar to that found by 
Manocha et al. [10] as 15.34±0.93 seconds, Rewari and Prabhu [11] as 
Table 1: MES model
S. No. Groups Pre-treatment
(mg/kg, i.p.)
Rats Onset time (mean±SEM in seconds) No extensor 
seizuresTonic limb flexion Tonic extensor Clonus Stupor Recovery
1  Group A (control) 3% gum acacia 6  5.5 ± 0.428 12.5±0.4282 5.333±0.421 139±5.526 162.33±5.590 0
2 Group B1 (test 1) EECM 50 6  4.833 ± 0.307 5.5±0.223
a 4.333±0.614 146±7.479 160.67±7.269 0
3 Group B2 (test 2) EECM 100 6 4.5±0.223 3.833±0.307
a 4.5±0.428 125.83±2.535 138.67±2.716a 0
4 Group B3 (test 3) EECM 200 6 4±0.258
a 2.167±0.307a 4.667±0.666 124.50±4.958 135.33±5.044a 0



















N=6 in each group; all the values were expressed in mean±SEM. ap<0.01 is significant when compared with control (ANOVA followed by Dunnett’s multiple comparison 
test). MES: Maximal electroshock seizure, EECM: Ethanolic extract of Citrus maximus, SEM: Standard error of mean, i.p.: Intraperitoneal
Table 2: PTZ-induced seizure model








Average duration of convulsions
(Seconds±SEM)
Number of animals 
recovered
1 6 3% gum acacia 670.33±25.43 1.677±0.210 14.583±0.374 6
2 6 EECM 50 1305.2±37.92 1 9.5±0.428 6
3 6 EECM 100 1610.5±28.40 1 7.667±0.557 6
4 6 EECM 200 2090±37.3 1 5.333±0.494 6










N=6 in each group; all the values were expressed in mean±SEM. P<0.01 is significant when compared with control (ANOVA followed by Dunnett’s multiple comparison 
test). PTZ: Pentylenetetrazol, EECM: Ethanolic extract of Citrus maximus, SEM: Standard error of mean, i.p.: Intraperitoneal
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11.6±0.40 seconds, and Achliya et al. [12] as 14.39±0.52 seconds in their 
respective control groups. The extensor phase in the three test groups, 
viz., Group B1, B2, and B3 were found to be 5.5±0.2236, 3.833±0.3073, 
and 2.167± 0.3073 seconds, respectively, which shows there was a 
reduction in its duration.
There was complete abolition of the extensor phase in the standard 
group of phenytoin. Similar effects were found with different doses of 
phenytoin by Chattopadhyay et al. [13], where there was reduction in the 
extensor phase of MES-induced convulsion. Phenytoin sodium exerts an 
antiepileptic effect by stabilization of the neuronal membrane, and thus, 
prolongation of recovery of inactivated sodium channels. On high doses, 
phenytoin can also block the calcium influx during depolarization [14]. 
There was a 0% incidence of mortality of rats in all the groups, which 
correspond to the findings of Sonavane et al. [15].
From the above findings, it can be said that the EECM leaves reduced the 
extensor phase of convulsion in the dose-dependent manner [16] with 
maximum effect seen at the dose of 200 mg/kg.
The seizure is produced by the PTZ-induced seizure model resembles in 
the absence or petit mal seizure in human beings. A drug which causes 
either delay or complete abolition of convulsions in the PTZ-induced 
seizure model has reportedly got anticonvulsant activity [7].
In the present study, latency to convulsion in the control group was 
670.33±25.438 seconds, and for the test groups B1, B2, and B3, it was 
found to be 1305.2±37.926, 1610.5±28.402, and 2090±37.3 seconds, 
respectively, which shows an increase in the latency with increasing 
dose. In the standard group of diazepam (4 mg/kg), there was complete 
absence of convulsions within the specified time of 60 minutes of 
observation after subcutaneous PTZ injection [6], which corresponds 
to the findings of Khosla and Pandhi [17], for their standard group 
(diazepam, 4 mg/kg) and Sonavane et al. [15]. There were convulsions 
in all (100%) the animals in the control and test groups of EECM, which 
correlates with the findings of Abed [18]. The incidence of convulsions 
in the control group of Ambawade et al. [19] was also found to be 100%. 
The number of convulsions in all the test groups was found to be 1, 
whereas it was 1.677±0.2108 in the control group.
The average duration of convulsions in the control Group A and the test 
groups B1, B2, and B3 was 14.583±0.3745, 9.5±0.4282, 7.667±0.5578, 
and 5.333±0.4944 seconds, respectively, which shows a decrease in the 
duration of convulsions with increasing dose. Animals were observed 
for 30 minutes to detect the onset of spasm and generalized tonic-clonic 
seizures and further up to 2 hr to detect mortality if any [20] animals 
devoid of seizures were considered as protected [21]. In this model of 
seizure, also it was found that there was no mortality of rats in any of 
the groups, and the maximum anticonvulsant activity was found with 
the 200 mg/kg dose.
Thus, from the above two seizure models of MES and PTZ, it can be 
concluded that EECM leaves have got an anticonvulsant effect in the 
increasing dose-dependent manner.
CONCLUSION
Thus, the present study showed that EECM leaves have got significant 
anticonvulsant effect, and it would be of great value to confirm these 
findings for different other doses and to find the exact mechanism 
of action with further studies on experimental animals and finally 
doing clinical studies to make it available for use in human beings in 
a commercial way. With the change in the global scenario toward the 
use of non-toxic herbal and ayurvedic medicines, development of more 
purified forms of C. maximus leaf extract should be emphasized for the 
control of seizures in the future.
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